Pressrelease – TATAA Biocenter Expands Offerings using Toray’s 3D-GeneTM microarrays

9th January

TATAA Biocenter, Europe´s leading provider of genomic services, is expanding its service offerings to high-throughput microRNA and mRNA profiling using Toray´s technology of 3D-GeneTM microarray.

“After extensive testing and validation of the various offerings on the market, we selected the Toray 3D GeneTM microarray platform for its superior performance combined with a most powerful workflow from sample preparation, profiling, data analysis and pathway analysis” – Dr. Mikael Kubista, founder and CEO of TATAA Biocenter.

TATAA_Toray_Pressrelease_130109